Tag Archives: raredisease

Sobi buys rare-disease drug emapalumab, zooms in on hematology and immunology

STOCKHOLM (Reuters) – Rare diseases specialist Swedish Orphan Biovitrum (Sobi) has agreed to buy the drug emapalumab and is reorganizing to increase focus on late-stage development in hematology and immunology. The drugmaker said on Wednesday it would buy a newly established company owning the drug candidate for the treatment of primary haemophagocytic lymphohistiocytosis (HLH), and… Read More »